Mesothelioma
 Navigation Links

Home

mesothelioma cancer

asbestos

mesothelioma lawyers

pleural mesothelioma

peritoneal mesothelioma

malignant mesothelioma

mesothelioma asbestos

mesothelioma treatment

mesothelioma lawsuit

mesothelioma symptom

mesothelioma information

mesothelioma diagnosis

malignant pleural

mesothelioma

mesothelioma law

mesothelioma law firm

mesothelioma litigation

mesothelioma definition

mesothelioma doctor

cause of mesothelioma

mesothelioma lawyer texas

mesothelioma settlement

mesothelioma help

mesothelioma injury

pericardial mesothelioma

mesothelioma research

lung cancer

benign tumors

Mesothelioma Research of Asbestos Exposure

Much of the mesothelioma research is spent how the cells are affected and changed by asbestos exposure. Drug companies and the government are the sponsors behind the research and development because mesothelioma research is extremely expensive. Mesothelioma is a form of cancer associated with asbestos exposure and is the subject of ongoing medical and scientific research. There are many organizations that are involved with the research of mesothelioma including the companies that are responsible for mesothelioma cancer through the exposure of asbestos at work.

The National Institute of Cancer is working very hard to cure mesothelioma, its symptoms and treatments. They currently sponsor clinical trials designed to find new treatments for people diagnosed with mesothelioma. These Mesothelioma Clinical Trials are being conducted on actual patients and may be a valuable treatment option for some patients. These trials are considered necessary to determine the effectiveness of new approaches to dealing with mesothelioma.

In the last few years, there has been a lot of attention on mesothelioma research.. Both the medical profession and many drug makers have focused attention on the disease. This has resulted in the development of promising new drug and chemotherapies including Alimta, which promise to re-define future cancer treatment. Alimta® (pemetrexed) in combination with cisplatin (Platinol®) was recently approved by the United States Food and Drug Administration (FDA) for the treatment of inoperable malignant mesothelioma. Alimta®/cisplatin is the first and only drug regimen proven to improve the duration of survival for patients with advanced malignant mesothelioma. Below are a few organizations that can provide you with more information about mesothelioma research.

The National Cancer Institute

If you need information immediately, please call 1-800-4-CANCER (1-800-422-6237), 9:00 a.m. to 4:30 p.m. local time, Monday through Friday; TTY 1-800-332-8615. Otherwise, send an e-mail to cancergovstaff@mail.nih.gov. Should your message require a response, you may expect one within 5 to 7 business days.

The U.S. Food and Drug Administration (aka FDA) can answer your questions about asbestos and new mesothelioma research.
Organization: Office of Consumer Affairs
U.S. Food and Drug Administration
Address: HFE-88, Room 16-85
5600 Fishers Lane
Rockville, MD 20857
Telephone: 1-888-463-6332 (1-888-INFO-FDA)

 

   
       
 

Sources of National Cancer Institute Information

Cancer Information Service
Toll-free: 1-800-4-CANCER (1-800-422-6237)
TTY (for deaf and hard of hearing callers): 1-800-332-8615

Contact Us


Copyright @ 2005 by Mesothelioma-Treatments.org